Proteus Digital Health, the ingestible sensor company that raised $45 million in May -- the largest funding raise in digital health this year so far -- has published the results of a small clinical trial in a peer-reviewed journal. The study of 27 adults with bipolar disorder or schizophrenia found that the addition of an ingestible sensor to their regiment led to 67 percent of patients taking...
Google's former Chief Health Strategist Roni Zeiger MD and Gilles Frydman, founder of the Association of Cancer Online Resources (ACOR), announced the launch of Smart Patients, a new online community for cancer patients and caregivers, at the TEDMED event in Washington DC last week.
"What we are primarily trying to do is help cancer patients and caregivers learn more effectively from each other...
The FDA has granted Class II prescription-only 510(K) clearance for an iPhone-enabled vision test. The software, called myVisionTrack, was developed by Vital Art and Science. The FDA clearance applies to the software when run on an iPhone 4S.
Vital Art and Science has developed the test for patients with serious degenerative eye conditions such as diabetic retinopathy (DR) and age-related macular...
Novartis Oncology, a division of the Switzerland-based pharmaceutical company, has added two new free Apple and Android apps to its catalog: My NET Manage and Clinical Trial Seek. Interestingly, one of their most high-profile apps, VaxTrak, has now disappeared from the Apple and Google Play stores.
My NET Manager is an app for patients with neuroendocrine tumors (or NET) to help them manage and...
A screenshot from Exco's clinical trial software.
One of our predictions at the start of the year was that 2013 would be a year for pharma to make big moves in mobile health. European pharmaceutical company AstraZeneca has begun that process, announcing a pilot, in partnership with Exco InTouch, to address chronic obstructive pulmonary disease (COPD) in the UK using mobile and online tools....
Omniscience Mobile's upcoming clinical trial app.
Mobile technology presents a sorely-needed, long-awaited opportunity for innovating the clinical trial – making it cheaper, easier, and even more accurate. But there are a lot of pieces to a clinical trial, and, according to some, mobile technology has the capacity to influence almost every one. Different companies are experimenting with these...
This week MobiHealthNews had a chance to discuss wireless health trends and activities at the West Wireless Health Institute with the Institute's new CEO Don Casey. We asked Casey to list five things the WWHI will accomplish in 2010, to point to some of the key challenges facing the wireless health industry and more.
MobiHealthNews: Name five things the WWHI will accomplish this year.
Casey: 1)...
The FDA recently approved MediSens Wireless' wireless body monitoring system, which assesses muscle and neuromotor functions in the upper extremities, for its first phase of clinical trials. MediSens' Clinical Movement Assessment System (CMAS) could be used by health care professionals working in physical medicine and rehabilitation, neurology, orthopedics and physical and occupational therapy....
The U.S. National Institutes of Health has an online database called ClinicalTrials.gov that includes a registry of federally and privately supported clinical trials underway or completed. The database currently boasts more than 81,000 clinical trials from some 170 countries. As you might expect a couple dozen of those trials are testing wireless health solutions -- mostly mobile phone...
UK-based wireless body area monitoring company Toumaz has begun a clinical trial of its peel-and-stick body monitoring system, Sensium, at London's St. Mary's Hospital. The trial is sponsored by Toumaz's U.S. partner CareFusion.
Toumaz's Sensium wireless band-aids continuously monitor patients' vital signs, including skin temperature, heart rate and respiration.
Toumaz founder Chris Toumazou...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
